文献速递腹部技术与安全US

肝动脉收缩期峰值流速与非多普勒超声观察指标预测急性胆囊炎的诊断效能比较及其对风险分类方法的影响

Hepatic artery peak systolic velocity compared to non-Doppler ultrasound observations for predicting acute cholecystitis: diagnostic performance and impact on a risk categorization approach.
PubMed 文献 · Abdom Radiol (NY) · 2024-11-22

在一家机构连续纳入2020年1月1日至2022年8月31日急诊科因急性胆囊炎行胆囊超声的885例患者(117例,13.2%确诊急性胆囊炎),比较肝动脉收缩期峰值流速(HAv)与非多普勒观察指标诊断急性胆囊炎的表现。HAv诊断AUC为66.3%,低于胆囊扩张(83.8%)、胆囊壁厚度(79.1%)和胆囊内容物(75.0%)。基于非多普勒观察指标求和评分的风险分类与HAv调整风险模型敏感度(84.6%)和特异度(85.2%)相同,但HAv调整风险模型AUC更高(91.3%,p 0.03)。

要点

  • HAv诊断急性胆囊炎AUC为66.3%,低于胆囊扩张83.8%、胆囊壁厚度79.1%和胆囊内容物75.0%。
  • 非多普勒风险分类与HAv调整风险模型敏感度84.6%、特异度85.2%相同,但后者AUC更高(91.3%,p 0.03)。
  • HAv评估使195例患者的风险分类得到调整,HAv调整风险模型可给出五级疾病概率。

核心结论

  • HAv诊断急性胆囊炎的效能低于其他观察指标;基于非多普勒观察指标求和评分的分类方法经HAv评估后得到改善,该风险分类方法可使放射科医生仅根据超声特征传达五级疾病概率,从有效排除急性胆囊炎到大幅提高患病可能性。

研究设计与样本

  • 在一家机构连续纳入2020年1月1日至2022年8月31日急诊科因急性胆囊炎行胆囊超声的885例患者,评估胆囊直径、胆囊壁厚度、胆囊内容物、胆囊周围不规则积液和肝动脉收缩期峰值流速(HAv),非多普勒观察指标评分求和后进行风险分类,并评估HAv分层对非多普勒风险分类中急性胆囊炎发生率的影响,重新分组建立HAv调整风险模型,采用AUC比较各参数、非多普勒风险分类和HAv调整风险模型的ROC曲线。

诊断标准与关键数值

  • 胆囊扩张诊断急性胆囊炎AUC为83.8%(p < 0.001),胆囊壁厚度AUC为79.1%(p < 0.001),胆囊内容物AUC为75.0%(p 0.02),HAv AUC为66.3%;非多普勒风险分类与HAv调整风险模型诊断急性胆囊炎的敏感度均为84.6%、特异度均为85.2%,HAv调整风险模型AUC为91.3%(p 0.03)。

临床应用与阅片要点

  • HAv调整风险模型可使放射科医生仅根据超声特征传达五级疾病概率,从有效排除急性胆囊炎到大幅提高患病可能性;HAv评估使195例患者的风险分类得到调整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Compare HAv to non-Doppler ultrasound observations for diagnosing acute cholecystitis in a large consecutive cohort of emergency department (ED) patients and establish a method to combine HAv assessment with non-Doppler observations for diagnosing acute cholecystitis.

METHODS: Consecutive ED patients at one institution undergoing gallbladder (GB) ultrasound (US) for acute cholecystitis between 1/1/2020 and 8/31/2022 had assessments of GB diameter, GB wall thickness, GB contents, pericholecystic irregular collection, and hepatic artery peak systolic velocity (HAv). The non-Doppler observations were scored and summed. Non-Doppler risk categorization was based on rate of acute cholecystitis associated with summed scores. The impact of HAv stratification on the rate of acute cholecystitis in the non-Doppler risk categories was evaluated, with regrouping when subgroups had changes in the acute cholecystitis rate; the regrouping established the HAv-adjusted risk model. Receiver-operator curves for acute cholecystitis diagnosis for individual parameters, the non-Doppler risk categorization, and the HAv-adjusted risk model were compared using area-under-curve (AUC) calculations.

RESULTS: Of the 885 patients in the study cohort, 117 (13.2%) had acute cholecystitis. The AUC for diagnosing acute cholecystitis using GB distention (83.8%, p < 0.001), GB wall thickness (79.1%, p < 0.001), and GB contents (75.0%, p 0.02) were higher than HAv (66.3%). HAv assessment adjusted risk for 195 patients. The non-Doppler risk categorization and the HAv-adjusted risk model had the same sensitivity (84.6%) and specificity (85.2%) for diagnosing acute cholecystitis, but the HAv-adjusted risk model showed higher AUC (91.3%, p 0.03) due to increased ability to exclude acute cholecystitis.

CONCLUSIONS: The diagnostic performance of HAv for acute cholecystitis was lower than other assessments. A categorization scheme based on summed points assigned to each non-Doppler observation was improved with HAv assessment. This risk categorization approach using formulaic integration of non-Doppler and Doppler assessments on ED patients allows radiologists to convey one of five levels of disease probability based solely on sonographic features ranging from effectively excluding acute cholecystitis to substantially elevating the chance the patient has the condition.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chen L, Patel AG, Dahiya N, et al. Hepatic artery peak systolic velocity compared to non-Doppler ultrasound observations for predicting acute cholecystitis: diagnostic performance and impact on a risk categorization approach. Abdom Radiol (NY). 2024. PMID: 39572430. doi:10.1007/s00261-024-04692-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。